Posts

FDA approved avatrombopag for thrombocytopenia in CLD patients scheduled for a procedure

 

  • On May 21, the FDA approved avatrombopag (DopteletⓇ, AkaRx Inc.) for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) scheduled to undergo a procedure.